Surmodics Cash Flow from Operating Activities 2010-2025 | SRDX

Surmodics cash flow from operating activities from 2010 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.

Surmodics Cash Flow from Operating Activities 2010-2025 | SRDX

Surmodics cash flow from operating activities from 2010 to 2025. Cash flow from operating activities can be defined as a company's cash flows from operations.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$229.5B
Boston Scientific (BSX)$155.7B
Stryker (SYK)$149.4B
EssilorLuxottica (ESLOY)$144.2B
Medtronic (MDT)$118B
Lonza Group Ag (LZAGY)$49.7B
Haleon (HLN)$43.4B
ResMed (RMD)$41.8B
GE HealthCare Technologies (GEHC)$34.1B
Agilent Technologies (A)$33.8B
Koninklijke Philips (PHG)$26.6B
Terumo (TRUMY)$26.2B
Insulet (PODD)$23.2B
Zimmer Biomet Holdings (ZBH)$21.3B
Smith & Nephew SNATS (SNN)$16.3B
Baxter (BAX)$12.6B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$8B
Lantheus Holdings (LNTH)$3.8B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Perrigo (PRGO)$3.3B
Prestige Consumer Healthcare (PBH)$3.2B
ICU Medical (ICUI)$3.1B
Haemonetics (HAE)$2.7B
LeMaitre Vascular (LMAT)$2.2B
Acuren (TIC)$2.1B
Curaleaf Holdings (CURLF)$2B
AtriCure (ATRC)$1.9B